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Comparing Population 
Health
Marina Karanikolos, Bernadette 
Khoshaba, Ellen Nolte and Martin McKee
5.1 Why measure population health outcomes?
The 2000 World Health Report (WHR2000) identifi ed three fundamental 
goals for a health system: improving the health of the population it serves; 
responding to the reasonable expectations of that population; and collecting 
funds to do so in a way that is fair (WHO, 2000). In this chapter, we focus on 
the fi rst of these: improving population health. Before doing so, however, we 
summarize briefl y the work that has taken place on this issue so far. 
The authors of the WHR2000 faced a challenge. They were required to esti-
mate performance for all 191 of the WHO Member States, of which only about 
60 had any data on causes of death. Consequently, the only measure of popu-
lation health outcomes available to them was mortality, and even then it was 
necessary to produce estimates for many countries, based on empirical rela-
tionships with other measures, such as economic status (McKee, 2010). This 
determined their chosen defi nition of the health system, which they decided 
would include “all activities, whose primary purpose is to promote, restore and 
maintain health”. The actual indicator used was disability-adjusted life years, 
which incorporated a measure of morbidity, but again this was estimated for 
most countries. 
This approach was the only one possible given the need to include so many 
countries. Although controversial, it has served as a basis for many of the 
subsequent developments in assessing health systems performance. It was also 
consistent with a considerable body of previous research on the performance 
of countries worldwide that had also used mortality-based measures of health 
outcome (although more often infant and under-fi ve mortality), which are 
available from Demographic and Health Surveys for many countries without vital 
registration systems. 
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Other research has focused on high-income countries where more data 
are available, creating the potential for more sophisticated analyses that take 
advantage of the availability of information on deaths by cause to develop 
indicators that more closely relate to the delivery of health care as opposed to 
broader social and economic factors (Arah et al., 2006). One use of these data is 
to measure avoidable mortality, defi ned as deaths that should not occur in the 
presence of timely and effective care (Nolte & McKee, 2004). 
Although avoidable mortality is clearly an advance on all-cause mortality, 
it too has a number of limitations, in particular, attribution of outcomes 
to particular policies or interventions, as will be discussed later. It is also 
limited in its defi nition of avoidable deaths, as it tends to limit them to 
deaths occurring below a specifi ed age (now typically 75), thus denying 
the contribution of health care to reducing mortality at older ages. This is 
in large part because of the diffi culty of assigning a single cause of death for 
those dying at old age while suffering from multiple disorders. Its focus on 
mortality also disregards the role of health care in reducing disability and 
discomfort. 
Other work takes advantage of data on the process of care and the outcomes 
of specifi c interventions, mostly drawn from the growing volume of adminis-
trative data in some countries. An example is the OECD’s HCQI project (Kelley 
& Hurst, 2006). 
We begin this chapter by exploring the differing defi nitions of a health system. 
We then describe contemporary usage of population health measures; the 
strengths and limitations of existing measures; and the methodological chal-
lenges to employing them to assess health systems performance. We conclude 
by exploring potential areas for further research and, specifi cally, the scope 
for using the concept of avoidable mortality and tracer conditions, both 
of which offer a set of complementary mechanisms to compare health 
systems across countries and over time. Finally, we discuss what they cannot 
tell us about health systems and the potential unintended consequences of 
using them. 
5.2 What is a health system?
The scope of what constitutes a ‘health system’ in a given setting varies. There 
are many activities contributing – directly or indirectly – to improving the 
population’s health that, in different countries, may or may not be included 
in what is considered to be the health system. For example, it is not always 
clear how much a health system can be held responsible for promoting healthy 
lifestyles and reducing the prevalence of risk factors in the general population. 
Policies that affect population health are often outside the direct control 
of the health system, such as tobacco and alcohol policies. In addition, the 
boundary with other sectors within a country can be indistinct. This is typically 
a problem with social care, with boundaries often being determined by diverse 
administrative arrangements. There are also differences in how areas such as 
medical education and research are dealt with in comparisons, although work 
on National Health Accounts seeks to address these issues.
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A further complication relates to the population covered by a given system. 
This may be determined by fi nancial and/or organizational arrangements 
exemplifi ed by multiple systems that vary in ownership. One example is the US 
health system, which represents a composite of multiple subsystems, comprising 
a mix of overlapping public and private elements, variously covering those in 
employment, older people (Medicare), those at the lower or no income scale 
(Medicaid), military personnel (Veterans Affairs), and others. Even in countries 
with nearly universal coverage, privately funded subsystems are common; for 
example, in the United Kingdom, about 10% of the British population have 
private insurance to supplement their coverage by the NHS (OECD, 2004). 
Elsewhere, administrative territorial divisions within countries may also 
challenge the defi nition of what should be considered to be the health system. 
For example, following political devolution for the constituent countries of 
the United Kingdom in 1999, responsibility for the NHS in Northern Ireland, 
Scotland and Wales was transferred to subnational governments, while the 
Department of Health retained oversight of the NHS in England. This has 
led to increasingly diverging health systems in the four countries, while the 
Department of Health remains responsible for UK-wide health matters, such 
as the control of infectious diseases, and for representing UK health policy in 
international and European fora. 
These issues add to the complexity of comparing health systems performance 
internationally and help to explain why WHR2000 adopted a broad defi nition 
of a health system, which includes “all activities and structures that impact or 
determine health in its broadest sense within a given society” (WHO, 2000). 
Arah et al. (2006) more specifi cally distinguished between the health system 
and health care system, with the former closely resembling the one adopted 
by WHR2000. In contrast, the health care system is defi ned as the “combined 
functioning of public health and personal health care services” that are under 
the “direct control of identifi able agents, especially ministries of health” 
(Arah et al., 2006) (see Chapter 2 for more details). A related issue concerns 
the boundaries with sectors such as social care, which are often determined by 
diverse administrative arrangements and thus may or may not be included in 
the defi nition of the health (care) system.
To some extent, the defi nition of the health (care) system will depend on the 
question being asked. While it is important to recognize the various distinctions, 
it is equally important to realize that, in practice, concepts are likely to mean 
different things to different actors and that the precise boundaries of health 
(care) systems remain diffi cult to defi ne, although it is important to keep in 
mind issues relating to sectoral boundaries, ownership and geography. 
5.3 Broader determinants of population health
Variation in health outcomes such as mortality is often used to explain the 
success or failure of health systems. However, the reasons for diversity in health 
patterns between and within populations are multifaceted, refl ecting a complex 
interplay of factors, ranging from underlying economic and political circum-
stances to more proximal risk factors, such as lifestyle-related determinants of 
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health, with health care also playing a role, as identifi ed by the health fi eld 
concept advanced by Lalonde (Lalonde, 1974). 
Irrespective of how narrow (or broad) our defi nition of a health system is, 
it is essential to begin with an understanding of the range of infl uences on 
population health. Figure 5.1 (WHO, 2009), which is itself a greatly simplifi ed 
representation of reality, indicates the complexity of interactions among 
different factors that contribute to the onset of, and ultimate mortality from, 
just one condition: ischaemic heart disease (IHD).
Some of these factors are clearly beyond the control of the health system, such 
as age and levels of income and education, although arguably health systems 
might indirectly exert infl uence to minimize the health impact of such factors 
through active engagement with other sectors in society with a more immediate 
impact on socioeconomic factors in particular. Similarly, changes in common 
behavioural risk factors for ill health, such as smoking, alcohol use and poor 
diet, through population-wide strategies tends to be outside the immediate 
control of health systems as they require close interaction and cooperation 
with other sectors (economy, education, etc.), although measures to address 
lifestyle factors such as smoking are usually, but not inevitably, initiated by 
Figure 5.1 Major factors leading to ischaemic heart disease
Adapted from: WHO, 2009.
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the health sector. Health professionals can also advocate for increases in taxes 
on cigarettes, or a ban on smoking in public places. It is equally possible to 
identify both individual and population-based measures to tackle the other 
intermediate risk factors identifi ed in Figure 5.1. 
Crucially, the health system, however broadly defi ned, cannot tackle these 
risk factors on its own; nor can it be held accountable for failure to reduce the 
resulting deaths that arise from a lack of action. This does not, however, absolve 
governments as a whole from responsibility, and it is possible to translate this 
model of disease causation into indicators of overall government performance 
on health. This is analogous to the way that commentators judge governments 
on their ability to achieve growth in gross national product (GNP); they are not 
expected to create growth directly by, for example, nationalizing manufacturing 
and services, but they are expected to create the conditions within which 
economic growth can take place. From this perspective, it is entirely appropriate 
to hold governments accountable for improvements in aggregate measures of 
health, such as life expectancy at birth, as well as for their implementation, or 
failure thereof, of evidence-based policies to reduce deaths from preventable 
causes and their corresponding risk factors. An obvious example of the latter 
is a ban on smoking in public places, which many European governments 
have introduced successfully, with rapid reductions in cardiovascular disease. 
However, this does not mean that a government must do everything itself. 
As the example in Box 5.1 shows, there is an important role for civil society, 
although ultimately, where others do not take action, governments must step 
in to advise, regulate or legislate where appropriate. 
The implication of this brief discussion is that governments should be held 
to account for progress in the overall health of their populations, in exactly 
Box 5.1 Sudden infant death syndrome prevention in the UK 
In the United Kingdom, a national campaign to prevent sudden infant 
death syndrome (SIDS) was launched in 1991 by a voluntary organization, 
the Foundation for the Study of Infant Deaths, as a result of the Avon 
study. After attracting wide media publicity, the government responded 
by issuing a policy statement to health professionals, followed by a 
national leafl et accompanied by television and press advertising (McKee 
et al., 1996). Prior to this formal campaign, the Foundation for the Study 
of Infant Deaths had issued a press release about the Avon research 
(Fleming et al., 1990) showing the ninefold increase in the probability of 
prone sleeping among sudden infant deaths. This attracted considerable 
media attention and, together with the publication of research from 
the UK and other countries, some health professionals began to advise 
a change in sleeping position before the offi cial campaign (Scott et al., 
1993). A combination of several factors (accumulation of research, active 
voluntary group, media coverage and capacity to review health policy) 
resulted in an almost threefold decrease in deaths attributed to SIDS in 
the UK between 1990 and 1991 (FSID, 2011). 
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the same way as they are judged on economic progress. This must, however, 
be informed by an understanding of the locus of authority; there is little point 
in holding a national government to account for failure to implement policies 
that are, constitutionally, the responsibility of regional authorities. 
In the next section we explore the strengths and weaknesses of various 
measures of population health as potential indicators of health system 
performance.
5.4 Common measures of population health
The most commonly used measures of population health, such as total mor-
tality, life expectancy, premature or infant mortality, years of life lost, DALYs, 
capture generic information on population health. Although informative, these 
measures are unable to distinguish between the health care input and the con-
tribution of other activities to population health status. This was circumvented 
by the adoption of a broad defi nition of a health system in WHR2000 (WHO, 
2000). However, as noted above, this is not a satisfactory solution. 
We begin, however, by reviewing the mortality-based measures most com-
monly used in assessing population health. These measures have been cat-
egorized into two groups: generic and disease/age-specifi c indicators. This is 
followed by a brief overview of morbidity and summary measures, and their 
current and potential use for international comparisons. Table 5.1 summarizes 
the most common measures of population health (including broader determi-
nants of health and risk factors), and demonstrates examples of indicators, their 
key methodological issues and potential policy uses. 
Generic indicators
Generic indicators are used to summarize the total mortality experience in a 
given population over a specifi c period of time. The most common examples 
are life expectancy and age-standardized death rates (SDRs). Other indicators 
include less informative crude mortality rates and standardized mortality ratios 
(SMRs). Their greatest advantage is the availability and relative reliability of 
data (at least in high-income countries), as well as ease of calculation and 
analysis. However, the absence of data on cause of death constrains the scope 
to infer the contribution of health care. These indicators do not show the direct 
link between health system performance and population health, as they are 
often crude and depend on numerous other factors (Anell & Willis, 2000). As 
these indicators mask contributions of specifi c causes of death and risk factors, 
caution is needed when seeking to attribute observed changes to health care. 
Age/disease-specifi c indicators
Infant mortality rate (the number of deaths in children within the fi rst year 
of life per 1000 live births) is often used as an indicator of quality of health 
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care. Worldwide, this is more widely available than all-age mortality (and thus 
life expectancy) as it is often taken from surveys (especially Demographic and 
Health Surveys). However, it is a poor measure of the contribution of health care 
as it combines neonatal and post-neonatal deaths, which have quite different 
causes. In the fi rst four weeks of life mortality is more sensitive to the quality 
of medical care, while post-neonatal mortality is more strongly associated 
with socioeconomic factors (Leon, Vågerö & Olausson, 1992), and does not 
necessarily refl ect the overall health system performance (Mathers, Salomon & 
Murray, 2003).The perinatal mortality rate (the number of stillbirths and deaths 
in the fi rst week of life per 1000 live and stillbirths) is also frequently used as 
an indicator of health systems performance. Problems affecting comparisons 
include: the varying application of the defi nition of a live birth (although 
supposedly standardized), especially at low birth weights; the increase in 
multiple births (which are at greater risk) as a consequence of new treatments 
for infertility; the need to consider differences in patterns of birth weight; 
the very small numbers of deaths now occurring in high-income countries 
(making rates unstable in small populations); and variation in the application 
of prenatal screening for congenital anomalies (often linked to policies on 
abortion) (Richardus et al., 1998; Garne et al., 2001; van der Pal-de Bruin et al., 
2002), although one study suggested that the last of these had been of limited 
importance in a longitudinal study of perinatal mortality in Italy (Scioscia 
et al., 2007). The interpretation of apparent differences among countries and 
over time is therefore problematic (Nolte & McKee, 2004).
Turning to older ages, age-standardized mortality rates by cause are easy to 
calculate and reliable data are available for all high- and many middle-income 
countries. However, despite the existence of a standardized system of disease 
classifi cation (the International Classifi cation of Disease (ICD)), some caution 
is required in both longitudinal and cross-sectional studies. First, there may 
be differences in interpretation of coding rules, especially those involving the 
treatment of multiple causes. These can change during the course of an ICD 
version. Second, although the classifi cation is revised regularly, there may be 
interim changes, such as the introduction of codes for human immunodefi -
ciency virus (HIV) disease during the 1980s when ICD-9 was used in most coun-
tries. Finally, different countries switch to new versions at different times and 
there may be differences in the effects of change among countries, making it 
necessary to undertake bridge coding exercises whereby a set of death certifi -
cates are coded using both old and new versions and then compared. Other 
issues include completeness of registration of deaths and, more often, of the 
population denominator, a growing problem with more mobile populations. 
An example of a disorder that has been examined as an indicator of health 
care quality is IHD, one of the most frequent causes of premature mortality in 
industrialized countries (Nolte, Bain & McKee, 2009). It has been estimated 
that about 40–50% of the total reduction in IHD in Western countries can be 
attributed to improvements in specifi c medical interventions (Beaglehole, 1986; 
Kesteloot, Sans & Kromhout, 2006) with the remaining decline attributed to 
the decrease in prevalence of risk factors, such as smoking, high cholesterol and 
hypertension (some of which can also be attributed to medical intervention) 
(Bots & Grobbee, 1996; Ford et al., 2007). However, cross-national comparisons 
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of mortality rates from IHD have to be interpreted in the context of policies in 
other sectors (such as agriculture, which infl uences traditional dietary patterns) 
and of cultural differences (in diet, for example), which infl uence the levels of 
prevalence and risk factors in specifi c populations (Box 5.2). Thus, the complex 
epidemiology of IHD means that this indicator on its own may not necessarily 
identify weaknesses in health care, but may also capture other environmental 
and socioeconomic factors. Persisting high levels of mortality from IHD usually 
indicate systematic problems that cover the entire course of the disease – from 
primary prevention and health promotion to treatment. 
In those cases where there are data on incidence and mortality, it is possible 
to calculate disease-specifi c survival. This is the average length of time that 
individuals survive following diagnosis. Survival rates are most frequently 
applied to cancer and have been infl uential in international and longitudinal 
B ox 5.2 Explaining differences in mortality trends from IHD
We have previously shown how the contribution of health care to changes 
in deaths from IHD remains contested and can be diffi cult to ascertain 
(Nolte, Bain & McKee, 2009). This can be illustrated by comparing 
research from the German Democratic Republic and Poland, both of 
which experienced substantial, and similar, declines in mortality in the 
1990s (Nolte et al., 2002). 
In Poland, this improvement has been largely attributed to changes 
in diet, with increasing intake of fresh fruit and vegetables, and reduced 
consumption of animal fat (Zatonski, McMicheal & Powles, 1998). 
The authors of that study judged the contribution of health care to be 
negligible. In contrast, the WHO MONICA project found a considerable 
increase in the intensity of treatment of acute coronary events in Poland 
between 1986–89 and the early 1990s (Tunstall-Pedoe et al., 2000). Yet 
a further complication is that a much higher proportion of deaths from 
IHD in Poland are sudden, compared with western European countries, so 
limiting the scope for health care to make a difference in the acute stage. 
This is a phenomenon that has also been noted in the neighbouring Baltic 
States and Russian Federation (Uusküla, Lamp & Väli, 1998; Tunstall-Pedoe 
et al., 1999) and has been related to binge drinking (McKee et al., 2001). 
The eastern part of Germany also experienced a substantial decline in 
mortality from IHD but here research has focused more on health care. 
There is evidence of intensifi ed treatment of cardiovascular disease during 
the 1990s (for example, an increase in cardiac surgery of 530% between 
1993 and 1997 (Brenner, Altenhofen & Boqumil, 2000). Although this 
may not necessarily translate into improved survival (Marques-Vidal et 
al., 1997), there has been a (non-signifi cant) increase in the prevalence 
of those with a history of myocardial infarction among east Germans 
aged 25–69 years between 1990–92 and 1997–98 which, given the 
accompanying decline in mortality from IHD, suggests that there has 
been improved survival (Wiesner, Grimm & Bittner, 1999).
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comparisons. However, there are a number of issues that must be taken into 
account. First, coverage by cancer registries is limited in many countries, either 
geographically (covering only certain regions in much of Europe (Coleman et 
al., 2008)) or in other ways (the American Surveillance Epidemiology and End 
Results (SEER) system systematically under-represents the African-American 
population with their poorer outcomes (Mariotto, Capocaccia & Verdecchia, 
2002)). Second, calculation of survival is critically dependent on consistent 
approaches to diagnosis. Countries with extensive screening activities will 
inevitably detect cases earlier but, if this confers no survival benefi t (as with 
prostate cancer), the survival will seem longer although the time of death is 
unchanged (lead time bias) (Desai et al., 2010). Countries with weak linkage 
systems may have a high proportion of Death Certifi cate Only cases, in which 
fi rst registration takes place at death. This may artefactually shorten recorded 
survival. Ideally, stage at diagnosis is recorded to facilitate adjustment for some 
of these factors, but such data are often unavailable. Nonetheless, cancer survival 
data, if interpreted suitably cautiously, can offer insights into various aspects 
of cancer service quality: timeliness, technical competence and adherence to 
protocols (Jack et al., 2003). 
International comparisons of cancer survival have shown substantial 
differences in performance among European countries (Verdecchia et al., 2007), 
suggesting variations in quality of care. However, this poses the question of 
why. Thus, it has been suggested that historically relatively poor cancer survival 
rates in the United Kingdom and Denmark may be because the gate-keeping 
function of primary care delays access to specialist investigation (Crawford, 
2010) but also that there may be high levels of stoicism among the population, 
leading to late presentation (Anderson & Murtagh, 2007). This issue is not, 
however, resolved. 
Dickman and Adami (2006) noted that, “in order to evaluate progress against 
cancer one must simultaneously interpret trends in incidence, mortality and 
survival” as none of the three measures is fully interpretable without knowledge 
of the other two. An example of combining this information is a recent study 
by Coleman et al. (2011), which shows how rapid improvements in survival 
following breast cancer in the United Kingdom, despite increasing incidence, 
are associated with an overall reduction in mortality (Figure 5.2). 
Measuring morbidity
One of the principle limitations of the measures discussed above is their focus 
on mortality. One attempt to circumvent this was the work of Bunker, Frazier & 
Mosteller (1994) that assessed the “magnitude of relief in treated patients” with 
a range of conditions (unipolar depression, osteoarthritis, terminal cancers, 
asthma, cataract, etc.). They constructed a symptomatic measure of relief based 
on the incidence of each condition, the average age of those suffering from 
them, the number of treated patients, and the expected years of survival, into 
which they factored the years of disability prevented by therapeutic interven-
tion (Bunker, 2001). The overall measure of improved physical or mental func-
tion, or prevented pain and suffering, is expressed in “potential years of relief 
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per 100 patients”. On average, the interventions achieved relief from approxi-
mately fi ve years of poor quality of life per individual (Bunker, 2001). Although 
providing different and potentially useful results, this technique is based on 
the inventory approach for mortality described in the next section, and thus 
is subject to the same methodological problems (Nolte, Bain & McKee, 2009). 
The main measures of morbidity are derived from self-reporting of perceived 
health status in population health surveys. Examples include the World Health 
Survey, European Core Health Interview Survey and various national surveys, such 
as the Health Survey for England and US National Health Interview Survey. These 
typically include a question on self-rated health (usually on a fi ve-point scale, 
but sometimes on a four-point scale) but the results are not specifi cally related 
to health care interventions. They are also subject to potential bias, as those 
with higher expectations of health often record their health as worse than those 
with lower expectations, even when they are similar on objective measures. 
This can, however, be addressed by the use of anchoring vignettes, in which 
Figure 5.2 Breast cancer survival, incidence and mortality in Australia, Canada, 
Denmark, Norway, Sweden and the UK 
Adapted from: Coleman et al., 2011.
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respondents are asked to allocate a health status to an imaginary subject with 
a specifi ed level of disability (King et al., 2004). While several countries have 
instituted regular surveys using relevant instruments, data are not necessarily 
comparable with similar surveys undertaken elsewhere, in particular when the 
data collection instrument cannot ensure cross-cultural equivalence. Where 
cross-national comparable instruments have been employed, these frequently 
tend to cover only a few countries, often building on small samples of uncertain 
representative power in participating countries. Elsewhere, surveys are not 
undertaken regularly, or perhaps only once, so data tend to become outdated 
(Nolte, 2010). Surveys also include a variety of disease-specifi c measures, some 
of which may be attributable to health care, such as blood pressure diagnosis 
and control. Within Europe, the New European Health Survey System (EHSS) 
promises to be a valuable source, while the Survey of Health, Ageing and Retirement 
in Europe (SHARE), along with the English Longitudinal Survey of Ageing, with 
which it is compatible, provide valuable data on older people. More detailed 
discussion of population-based surveys is provided in Chapters 7 and 11. 
In some limited cases, the incidence of specifi c diseases may be useful in 
comparing health system performance. Thus, the OECD HCQI project includes 
the incidence of vaccine-preventable diseases (pertussis, measles, hepatitis B) in 
its set of indicators. The rationale for this is that the incidence of these diseases 
should be minimal in the presence of appropriate health care intervention 
(immunization). Variations in notifi cation requirements and prevention 
practices can affect incidence rates for these conditions. 
Routinely collected data on health service utilization, such as inpatient 
admissions or number of general practitioner (GP) consultations, while often 
cited as measures of performance, have a limited value. They are often based 
on unrepresentative samples of activity; may say only a little about those in 
need of care but not receiving it; and take no account of whether the activity 
is necessary. 
Finally, there are a number of population-based disease registries, although 
typically established within the framework of research projects. However, not 
all registries cover entire populations or all population groups (see cancer 
survival above). In some cases these may be part of international initiatives so 
that the data are, to some extent, comparable across countries. They may also 
be quite unrepresentative of the countries in which they are located as they are 
likely to be based on centres of excellence. 
Summary measures
Death rates in industrialized countries have now fallen to historically low levels, 
giving rise to ageing populations, often with substantial levels of disability. 
This has led to efforts to combine mortality and disability, with measures 
such as health-adjusted life expectancy (HALE) and DALYs. The advantage 
of summary indicators is their ability to combine the key elements of adverse 
health outcomes – mortality, morbidity and disability. Typically, summary 
measures of health are divided into two broad categories: health expectancies 
and health gaps. 
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Health expectancy is a measure of how long people can expect to live free of 
certain diseases or limitations to their normal activities (active life expectancy, 
disability-adjusted life expectancy, health-adjusted life expectancy, etc.). With 
this measure, less weight is assigned to years lived in less than full health. Healthy 
life expectancy has been used to establish the relationship between population 
health and health system inputs in 191 countries (Evans et al., 2001). A recent 
report of the Commonwealth Fund used healthy life expectancy at age 60 as 
one of three measures of productive and healthy lives in seven OECD countries 
(Australia, Canada, Germany, Netherlands, New Zealand, UK and the United 
States) as one of the measures demonstrating the ability of a health system to 
ensure long and healthy lives (Davis, Schoen & Stremikis, 2010).  
Health gaps quantify the difference between a designated norm for the 
population (e.g. 75 years in good health) and actual levels of health. These are 
usually expressed as years of life lost (YLL), which do not include years lived 
with disability, or DALYs, which do.
The latter involve applying a weighting to years lived with disability so as to 
reduce their value. This is typically done in one of three ways. The fi rst is the 
time-trade-off, in which respondents are asked to choose between remaining 
in a state of ill health for a period of time or being restored to perfect health 
but with a shorter life expectancy. The second is the standard gamble, where 
they are asked to choose between remaining in a state of ill health for a period 
of time or choosing an intervention which may either restore them to perfect 
health or kill them. The third is the visual analogue scale, in which they are 
asked to rate a state of ill health on a scale from 0 to 100, with 0 representing 
death and 100 representing perfect health. Other refi nements include placing 
a higher value on a year of life lived at certain ages (typically between 10 and 
55) and a lower value in childhood and old age. The advantage of this approach 
is “to combine information on mortality and non-fatal health outcomes to 
represent the health of a particular population as a single numerical index” 
(Murray & Salomon, 2002). 
Key methodological issues facing those using summary measures of health 
status relate to conceptual differences in the approaches taken and data 
limitations (Etches et al., 2006). The defi nitions, measurement and weighting 
of disability as applied to particular health states are complex and have long 
been controversial. For example, some commentators have expressed ethical 
concerns about the way this methodology places a value on life (Gold, Stevenson 
& Fryback, 2002), exemplifi ed by its use in the Global Burden of Disease project 
(Lopez et al., 2006). 
A further issue, when extended beyond high-income countries, is that mor-
tality data may not be available. In these cases, health outcomes are modelled 
based on known associations between mortality and other, typically economic, 
variables. All of these mortality-based measures of population health provide 
valuable information on the overall progress of nations but say relatively little 
about the contribution of health care. 
At present, comparable health status data are not available for all countries, 
so existing summary measures of population health are typically based on 
estimates of the prevalence of various health states (Mathers et al., 2003). This 
makes it diffi cult to assess trends over time, as any observed variation may 
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simply refl ect changes in data used to generate estimates. Thus, where levels of 
health are modelled using equations incorporating economic measures, booms 
or busts can create artifi cial changes in estimates of life expectancy or disease 
burden. A New Global Burden of Disease (2010) Study aiming to provide more 
continuity at corporability to health data across the globe and addressing some 
of the issues raised in preceding versions were released at the end of 2012.
Most of the indicators mentioned above are available in the public domain, 
from the WHO (European Health for All database, Global Health Observatory, 
Global Mortality Database), World Bank (World Development Indicators) or 
European Commission (Eurostat) websites. 
In summary, mortality-based measures of population health are attractive 
due to their availability and accuracy, particularly for high-income and most of 
the middle-income countries. The data needed to construct generic mortality 
indicators are readily accessible in high-income countries and indicators are 
easy to calculate. Age/disease-specifi c rates can potentially indicate weaknesses 
in the health system. Morbidity data are generally less widely available or con-
sistent, often relying on self-reporting and over-representing those who actively 
seek care. Summary measures of population health combine both mortality and 
morbidity information; however, the methodology (DALY weightings of health 
states and age) and validity of measures of health system performance remain 
controversial. Thus, of the common measures of population health, such as 
mortality (infant, perinatal, total), life expectancy, morbidity, or summary 
derivatives, only a select few are able to distinguish the components of the 
overall burden of disease that are attributable to health systems and those 
which result from factors arising elsewhere, while disease-specifi c indicators, 
such as mortality from IHD or cancer survival rates, can only refl ect isolated 
elements of the overall service. Consequently, assessment of the performance 
of health care requires identifi cation of the indicators of population health that 
directly refl ect health care (see section 5.6). Differences in data collection and 
registration practices need to be understood when comparing these indicators 
across countries or time.
5.5 The contribution of health care to population health
There has been long-standing debate about whether health services make a 
meaningful contribution to population health (McKee, 1999). In the late 1970s, 
several authors argued that health care had contributed little to the observed 
decline in mortality that had occurred in industrialized countries over the 
preceding century or so. Among them was Thomas McKeown, who showed 
how much of the decline in mortality from tuberculosis (TB) in England and 
Wales between 1848–1854 to 1971 predated the introduction of immunization 
and effective chemotherapy (McKeown, 1979). He explained this decline by 
factors acting outside the health care sector, such as improvements in living 
conditions, behavioural change and, most importantly, changes in nutrition 
(McKinlay & McKinlay, 1977; Cochrane, St Leger & Moore, 1978; McKeown, 
1979). Others, such as Illich, argued that developments in health care in the 
1950s and 1960s were actually damaging to population health, introducing 
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the term iatrogenesis (physician-produced disease) (Illich, 1976). Illich was 
especially concerned with the role of medicine as a form of social control. 
Recent writers have taken a more nuanced approach. They have noted 
how there has been a revolution in the therapeutic armamentarium since the 
1960s. Thus, Mackenbach showed how the rate of decline in infectious disease 
mortality doubled in the Netherlands after the introduction of antibiotics in 
1946, while mortality rates from common surgical procedures and perinatal 
conditions improved markedly after the 1930s (Mackenbach, 1996). However, 
even McKeown’s example of TB has been revisited, with more recent work 
attributing part of the reduction in mortality that predated the introduction of 
antibiotics to public health interventions, such as the segregation of patients 
with active disease (Fairchild & Oppenheimer, 1998). Furthermore, a study of 
changes in age-specifi c mortality showed how, although the acceleration in the 
overall death rate was small, the fi rst 10 years after introducing chemotherapy 
(1945–1955) were marked by striking year-on-year reductions in TB mortality 
rates among young people in England and Wales (Nolte & McKee, 2004).
At present, therefore, there is a general consensus that, while McKeown 
and others were broadly correct in pointing to a relatively limited role of 
curative medical measures in mortality decline prior to the mid-20th century 
(Colgrove, 2002), the scope of health care and its contribution to population 
health has progressed dramatically since the mid-20th century. Advances in the 
pharmaceutical and technology sectors have transformed acute fatal diseases 
into treatable or manageable conditions (such as infectious diseases and type 
1 diabetes). These developments, along with more effective ways of organizing 
health care (such as introducing multidisciplinary stroke units or integrated 
screening programmes) and the implementation of evidence-based medicine, 
have ensured a growing contribution of the health care sector to population 
health.
This raises the question of how to quantify the contribution of health care 
to reduced mortality. This is rarely straightforward. In some cases, the impact 
of health care is self-evident: examples include vaccine-preventable diseases, 
antibiotic treatment of acute infections and the introduction of insulin for 
type 1 diabetes. However, more often, the impact of health care is less easily 
quantifi able. Thus, in the last 30 years, there have been substantial reductions 
in mortality from many chronic diseases; while health care has contributed to 
these reductions, there have also been declines in exposure to many common 
risk factors and, thus, the incidence of disease. 
We begin by examining the key approaches that seek to quantify the 
contribution of health care to population health. These are the inventory 
approach and the production function approach (Buck, Eastwood & Smith, 
1999; Nolte & McKee, 2004). Two others – avoidable mortality and the use of 
tracers – are described in more detail later in this chapter.
The inventory methodology examines selected health services and their infl u-
ence on the burden of disease in a target population. McKinlay and McKinlay 
(1977) noted that much of the decline in mortality in the United States between 
1900 and the early 1970s was due to falling deaths from infectious disease, 
and that at least some of this must have been attributable to medical interven-
tions such as antibiotics and vaccines. They then calculated, for 10 infections, 
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the contribution to the overall mortality decline since 1900 made by reduc-
tions in deaths from these infections occurring after the relevant interventions 
had been introduced. As most of these interventions came about when death 
rates had already fallen substantially, they estimated that the interventions had 
contributed only about 3.5% of the total mortality decline. They rejected the 
idea that there were interventions that might have contributed to falls in any 
chronic diseases. More recent work by Bunker et al. (1994) sought to quantify 
the contribution of individual medical interventions to life expectancy and 
quality of life in the United States between 1950 and 1989, combining pub-
lished evidence on the effectiveness of specifi c clinical preventive and curative 
interventions and data on the prevalence of the corresponding diseases. They 
estimated that about half of the 7–7.5 year gain in life expectancy observed 
could be attributed to these activities (Bunker, 2001). A different methodology 
was adopted by Wright and Weinstein (1998), stratifying the population into 
those with average or elevated levels of disease risk and those with established 
disease, and then measuring the impact of preventive and therapeutic interven-
tions on gains in life expectancy. For instance, they estimated that a reduction 
of cholesterol to 200 mg/dl would result in between 50 to 76 months’ gain in 
life expectancy in a 35-year-old person with elevated cholesterol (>300 mg/dl). 
In comparison, quitting smoking in a 35-year-old at average risk of cardiovas-
cular disease would yield a 8 to 10 month gain in life expectancy. Cutler and 
McClellan (2001) looked at the cost of providing improved care, analysing the 
contribution of technology to fi ve selected conditions and fi nding that four 
of them (heart attack, low birth weight, depression, cataracts) had yielded net 
monetary benefi ts.   
Analyses based on an inventory approach provide essential information about 
the potential contribution of health care to population health. However, they 
rest on the assumption that the health gains reported in clinical trials translate 
directly to the population level (Nolte et al., 2011). This is not necessarily 
the case (Britton et al., 1999) as trial participants are often highly selected 
groups, typically excluding elderly people and those with comorbidities, even 
though these groups often dominate the population that will require treatment. 
Also, evaluations of individual interventions fail to capture the combined 
effects of integrated individualized packages of care (Buck, Eastwood & 
Smith, 1999), or indeed of the entire system, on population health. These 
fi ndings thus provide only a partial insight into what health systems actually 
achieve in terms of health gain or how different systems compare (Nolte, Bain 
& McKee, 2009). 
One other method is the production function approach. This typically uses 
regression analysis to examine how health care inputs (and other explanatory 
variables) affect a specifi c health measure (outputs). The fi ndings of such analyses 
have produced mixed results. Earlier work failed to identify strong and consistent 
relationships between health care indicators (such as health care expenditure 
or number of doctors) and health outcomes (such as infant mortality rate or 
life expectancy), but found socioeconomic factors to be powerful determinants 
of health outcomes (Martini et al., 1977; Kim & Moody, 1992; Babazono & 
Hillman, 1994). However, more recent work suggests alternative conclusions. 
Signifi cant inverse relationships have been established between health care 
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expenditure and infant and premature mortality (Crémieux, Ouellette & Pilon, 
1999; Or, 2000; Nixon & Ulmann, 2006), and between the number of doctors 
per capita and premature and infant mortality, as well as life expectancy at age 
65 (Or, 2001). 
A related methodology involves comparisons of the ways in which health 
care systems are organized. A study by Elola, Daponte and Navarro (1995) 
categorized 17 health systems in Europe into National Health Service (NHS) 
systems (such as Denmark, Ireland, Italy, Spain and the United Kingdom) 
and social security systems (such as Germany, Austria and the Netherlands). 
This analysis concluded that countries with NHS systems achieve lower infant 
mortality rates than those with social security systems at similar levels of gross 
domestic product (GDP) and health care expenditure. On the other hand, van 
der Zee and Kroneman (2007) conducted a longitudinal analysis of trends in 
Europe from 1970 onwards. Their results suggest that the relative performance 
of the two types of system changed over time and that social security systems 
have achieved slightly better outcomes (in terms of total mortality and life 
expectancy) since 1980, when inter-country differences in infant mortality 
became negligible. The myriad of other factors involved makes such analyses 
almost impossible to interpret.
All these approaches have obvious limitations arising from data availabil-
ity and reliability. However, the production function approach also fails to 
take account of lagged relationships, as noted by, for example, Gravelle and 
Blackhouse (1987). An obvious example is cancer mortality, where death rates 
often refl ect treatments undertaken up to fi ve years previously. Their cross-
sectional nature is ill-equipped to address causality adequately, and such models 
often lack any theoretical basis that might indicate what causal pathways may 
exist (Buck, Eastwood & Smith, 1999). The complex pathway between increased 
inputs and health outcomes also means that there are likely to be many unrec-
ognized confounders. Analyses undertaken so far tend to lack a sound theoreti-
cal basis and, in particular, provide little insight into the mechanisms involved. 
However, the greatest problem is that the majority of studies of this type 
employ indicators of population health (for example, life expectancy and total 
mortality) that are infl uenced by many factors outside the health care sector. 
These include policies in sectors such as education, housing and employment, 
where the production of health is a secondary goal. This raises concern that the 
observed relationships are due to confounding. An example of the potential pit-
falls is provided by the fall in infant mortality in the two formerly divided parts 
of Germany in the 1990s that, on closer inspection, can be seen to be due to a 
fall in neonatal mortality in the east (most likely due in large part to improved 
health care) and in post-neonatal mortality in the west (which has different 
causes) (Nolte et al., 2000).
5.6 A way forward
The reason why the measures discussed in the previous sections are so often used 
for performance measurement is because they are available. It is important to 
ensure that any new performance indicators are driven by what is theoretically 
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meaningful, rather than simply available. As has been noted previously, the 
fundamental role of performance measurement is to provide the necessary 
information to support health system improvement (Smith, 2009). Capturing 
the differences in health system performance in a systematic and comparable 
way requires other approaches. 
The next section of the chapter will discuss two complementary approaches – 
avoidable mortality and tracers, which have been used in recent years to 
capture information on different aspects of health systems. 
Avoidable mortality
The concept of avoidable mortality was initially developed by Rutstein in 
the 1970s. It is based on a notion that certain deaths should not occur in the 
presence of timely and effective medical care (Rutstein et al., 1976). Later, 
Charlton et al. (1983) proposed a list of specifi c conditions amenable to health 
care. In time, this evolved to refl ect new epidemiological research and advances 
in medical care. The concept was adopted by a wide range of researchers in 
Europe in the 1980s and early 1990s, as it was seen as a potential tool to assess 
the performance of health systems. The publication of the European Community 
Atlas of Avoidable Deaths and its subsequent editions in 1988, 1991 and 1997 
served as a major stimulus for a series of analyses at national level across many 
of the high-income countries (Nolte & McKee, 2004). 
This is, however, an area where there has been some confusion about 
terminology (Kamarudeen, 2010). Avoidable mortality, in its broadest sense, 
includes deaths considered to be avoidable by appropriate and timely medical 
care, as well as those preventable by population-based interventions. ‘Amenable 
mortality’ is often considered to be a subset of avoidable mortality, including 
only those conditions directly amenable to health care, “from which it is 
reasonable to expect death to be averted even after the condition develops” 
(Nolte & McKee, 2004). In contrast, ‘preventable’ deaths are usually taken to 
include deaths from conditions that can be prevented by population-based 
interventions but where the contribution of health care may be limited once 
the condition has developed. Examples include lung cancer, alcoholic liver 
disease and suicides. These can, however, be used as an indicator of overall 
government performance, as noted above.
In 2004, Nolte and McKee undertook a systematic review of the work on 
avoidable mortality then available, revised the list of causes of death consid-
ered to be amenable to health care, and applied this to 12 EU countries (Nolte 
& McKee, 2004). They adopted a defi nition of a health system that covered 
primary and hospital care, as well as primary and secondary prevention (includ-
ing immunization and screening). The objective was to investigate the impact 
of health care on changing patterns of mortality and life expectancy in the 
1980s and 1990s. Since the 1980s, all countries examined had experienced an 
increase in life expectancy, although the pace of improvement varied. For most 
of these countries, the greatest reductions in amenable mortality were achieved 
in the 1980s. During the 1990s, the decline slowed, particularly in the coun-
tries where mortality from amenable causes was already low, as in Northern 
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Europe. However, even there, amenable mortality still continued to fall, albeit 
at a slower pace. 
Newey et al. (2004) demonstrated similar results for the older members of 
the EU. Notably, most of the countries that had joined the EU in 2004 
experienced relatively small reductions in amenable mortality in the 1990s, 
at a time when their health systems were undergoing major reconfi guration, 
but the authors (correctly) predicted that several would begin to close the gap 
in the 2000s, once the major structural and economic reforms had become 
embedded. 
In a subsequent analysis of 19 industrialized countries between 1997–1998 
and 2002–2003 (Nolte & McKee, 2008), the largest reductions in amenable 
mortality were seen in many of the countries with the highest initial levels. 
However, the United States experienced hardly any reduction from its 
initial high level, so that it increasingly lagged behind other industrialized 
countries.
Other research by the same authors has shown how the USSR lagged 
increasingly far behind western Europe from the mid-1960s onwards, refl ecting 
its failure to modernize its health care system to address the rising tide of chronic 
diseases (Andreev et al., 2003), while another study showed the acceleration 
in the rate of improvement of amenable mortality in China, Taiwan following 
the introdu ction of national health insurance in the 1990s (Lee et al., 2010). 
The importance of health care was also apparent from an analysis of trends 
in amenable mortality in New Zealand (Tobias & Yeh, 2009). This concluded 
that, over the preceding 25 years, improvements in health care contributed 
approximately one-third to the overall improvement in life expectancy. 
Together, these fi ndings support the notion that improvements in access to 
effective care have a measurable impact in industrialized countries, and that 
the concept of amenable mortality may provide a valuable indicator of health 
system performance overall. 
The precise composition of lists of causes deemed amenable to health care 
may not be of great importance. This is the conclusion of a recent report by the 
OECD (Gay et al., 2011) that compares the impact of two slightly different lists, 
by Nolte and McKee (2008) and Tobias and Yeh (2009). As Figure 5.3 shows, 
both produce similar results.
Amenable mortality does, however, suffer from a number of limitations. 
As an aggregate measure, it summarizes a wide range of causes of death, each 
refl ecting different aspects of the health system. It is therefore necessary to 
break down the overall fi gures by cause and age to understand what is driving 
any change. This may be diffi cult where there are small numbers in particular 
groupings, as will be the case in all but the largest countries. Indeed, this is 
an increasingly important problem as deaths from many causes in those aged 
under 75 reach very low levels.
Second, aggregate data conceal variations within populations, which can be 
divided according to geographic, ethnic, socioeconomic and other parameters. 
Improvements for one group may conceal deteriorations for others (Nolte & 
McKee, 2008). 
There are, however, some more fundamental problems with the concept 
that must be addressed (Nolte & McKee, 2004). One is the variable lag between 
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Figure 5.3 Amenable mortality in OECD countries, 2007
Adapted from: Gay et al., 2011.
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medical intervention and mortality. In some cases this will be instantaneous, 
as in the case of resuscitation following cardiac arrest. Here, the outcome can 
reasonably be attributed to intervention in the same year. However, cancer 
survival is measured after fi ve years and, while there is often a sharp reduction 
in survival at the time of treatment, there is a slower decline over several 
years. Thus, a death may be attributable to treatment decisions up to fi ve years 
previously. In other cases the lag may be much longer. Helicobacter eradication 
therapy in a young person may save them from dying from stomach cancer 
several decades later. 
Another concern is the changing incidence of disease. Deaths from amenable 
causes will decline if the incidence is falling regardless of any change in health 
care, and vice versa. 
The original list of amenable causes included causes of death that could 
be prevented entirely by health care as well as those from which some 
deaths would be inevitable but this number could be minimized. The 
former is exemplifi ed by vaccine-preventable diseases such as measles; the latter 
by IHD, where even in the best performing health care system, there will be 
some sudden and unobserved deaths. However, there are also many causes 
of death not considered to be amenable where, in some circumstances, 
health care can be life-saving. This is true of many cancers for which a small 
proportion may be identifi ed early making curative treatment possible. 
An example is cancer of the pancreas. This begs the question what pro-
portion of deaths from a specifi c cause should be preventable in order for the 
cause to be considered amenable. This issue has previously been addressed 
only implicitly. 
One approach to doing so is to determine what has led to a reduction in 
avoidable deaths. In some cases, there will have been a single intervention. 
The term ‘magic bullet’ recalls the dramatic benefi ts of penicillin when it was 
fi rst given to patients with severe staphylococcal infections in the 1940s. More 
often, health care will prevent deaths through a combination of interventions 
introduced incrementally, perhaps over decades. In these cases, it is necessary to 
look at changes in death rates over considerable time, introducing the problem 
of attribution as it is necessary to exclude other explanations for observed 
changes. This is, however, complicated by the limited evidence available. As 
noted above, randomized controlled trials often have limited external validity, 
as they frequently exclude both children and older people; those with comor-
bidities; and, historically, women. Hence, it will often be necessary to draw on 
natural experiments where it is possible to determine when new treatments 
were introduced. An example is the introduction of highly active antiretrovi-
ral therapy (HAART) for patients with acquired immunodefi ciency syndrome 
(AIDS), where death rates fell very rapidly. In other cases, even where detailed 
data are unavailable, it may be possible to infer the impact of health care where 
there has been wider system change. An example is the political transition in 
Eastern Europe around 1990. The opening of borders to modern pharmaceu-
ticals and ideas of evidence-based medicine made it possible to provide treat-
ment that had been previously denied to sufferers from many chronic diseases. 
Thus, in countries such as Estonia, there was a rapid decline in mortality from 
stroke, almost certainly as a result of better treatment of hypertension, at a time 
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when such deaths were increasing in the neighbouring Russian Federation. It 
may also be necessary to look at historical evidence: conditions such as acute 
appendicitis became amenable to health care once the introduction of asepsis 
and anaesthesia made intra-peritoneal surgery possible in the late 19th century. 
The treatment of hypertension has a shorter history but has still been possible 
since the late 1950s. 
In all previous studies, the defi nition of amenable deaths has had an upper 
age limit, refl ecting the view that “everyone must die of something”. The age 
limit has increased over time, from 65 to 75, but this creates certain problems. 
The fi rst is that it is explicitly ageist, as it devalues curative care for those aged 
over 75. The second is empirical: life expectancy in some countries now exceeds 
this fi gure and also there is growing evidence that many types of health care are 
very effective in older people. If, however, the defi nition of an amenable cause 
is one where health care can reduce the death rate by 50% or more, then there 
is no intrinsic reason to have an upper age limit. However, while conceptually 
attractive, this also poses problems of obtaining evidence, fi rstly because older 
patients are often excluded from trials and, second, because the absence of an 
observed decline in mortality at older ages at a time when an intervention 
was being introduced may simply mean that this population was not offered 
treatment. 
Amenable mortality is a dynamic concept. Although most defi nitions still 
include infectious diseases such as measles, the numbers of deaths in high-
income countries are negligible. In other words, success in tackling causes of 
death amenable to health care renders these causes obsolete as indicators of 
future progress. At the same time, new treatments are discovered that render 
once untreatable conditions treatable, justifying their inclusion in a new 
categorization. This clearly poses problems for longitudinal analyses. 
Finally, the scope for reducing rates of avoidable mortality is greatest in the 
countries where initial levels are high. As a consequence, the ability to compare 
health system performance among developed countries is likely to be limited 
in the future, as the differences will be relatively small. Also, changes in coding 
of cause of death and in ICD versions may create artefactual discontinuities. 
It is also necessary to take account of changes in the incidence of underly-
ing disease. For all these reasons, superfi cial comparisons of amenable mortal-
ity may be misleading (Desai et al., 2011). Yet, despite these limitations, the 
concept of avoidable mortality provides a potentially useful indicator of health 
system performance. It is, however, important to recognize that high levels 
should not be taken as defi nite evidence of ineffective health care, but rather as 
an indicator of potential weaknesses that require further investigation. These, 
and some of the earlier problems noted, can be illustrated by reference to renal 
cancer. In some countries, death rates are increasing and yet, paradoxically, 
data from cancer registries suggest that fi ve-year survival rates are improving. 
Several factors must be considered. As this is a smoking-related cancer, the inci-
dence is continuing to increase among women. There have also been advances 
in treatment, although of uncertain benefi t. Finally, reported cancer survival 
is subject to lead-time bias as the greater use of abdominal imaging techniques 
in place of barium studies for intestinal problems is identifying many more 
early tumours. 
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The tracer concept 
Many of the aggregate indicators discussed above say little about what must 
be done to improve the outcomes of health care so the policy implications are 
often unclear (Walshe, 2003).The challenge is to develop techniques that can 
capture performance in a systematic and comparable way. The use of tracer 
conditions is based on the premise that carefully selected health problems can 
provide insights into the performance of different elements within the overall 
health system (Nolte, Bain & McKee, 2006, 2009). 
The concept was proposed initially by Kessner, who set out the six criteria for 
a condition to be used as a tracer (Kessner, Kalk & Singer, 1973):
1.  functional impact, i.e. requires specifi c treatment, otherwise resulting in 
functional impairment;
2.  well defi ned and easy to diagnose; 
3.  suffi cient prevalence in the population to permit collection of adequate data; 
4.  natural history which varies with utilization and effectiveness of health care; 
5.  available techniques of medical management which are well defi ned for at least 
one of the following: prevention, diagnosis, treatment, or rehabilitation;
6.  known epidemiology.
Over the past 30 years, the application of the tracer methodology has 
expanded slowly, as it has the potential to identify strengths and limitations 
of the entire health system. It is important to note that this approach does not 
assess the quality of care per se, but rather identifi es potential strengths and 
weaknesses of the system’s response to tracer conditions. 
The process involves the collection of data from a variety of sources, 
including surveys and interviews with patients, providers and policy-makers. 
The assessment focuses on the inputs of care (physical, such as facilities and 
pharmaceuticals; human, such as trained health workers and empowered 
patients; knowledge, such as evidence-based guidelines; and social, such as 
social support and communication systems) and their integration.
The selection of health problems suitable for the tracer concept depends 
on the specifi c health system features requiring assessment. Thus, public 
health policies at the system level can be evaluated using vaccine-preventable 
conditions, while neonatal mortality can be adopted as a possible measure for 
assessing access to health care (Koupilová, McKee & Holcik, 1998; Nolte et al., 
2000).
The increasing burden of chronic diseases, along with their complexity, 
makes then especially suitable for use as tracers, given that they require the 
coordinated input of multiple elements of the health system. Various studies 
have now used diabetes mellitus to evaluate health system performance mea-
surement in high-, middle- and low-income settings (Hopkinson et al., 2004; 
Beran, Yudkin & de Courten, 2005; Nolte, Bain & McKee, 2006). Diabetes fi ts 
the criteria for a tracer condition, as it is well defi ned, fairly easy to diagnose 
(WHO, 1999) and common. Diabetes outcomes refl ect a range of aspects of 
health system performance. 
Crucially, albeit with some caution, the identifi cation of failings in the 
provision of care for one chronic disorder can often highlight failings affecting 
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many others. McColl and Gulliford (1993) classify deaths from diabetes among 
young people as “sentinel health events” that should raise questions about the 
quality of health care delivery. Effective treatment prevents complications and 
disability, which is clearly illustrated by the countries with limited access to 
insulin (Yudkin & Beran, 2003) and by countries where health systems have 
collapsed (Telishevka et al., 2001). 
Despite the availability of effective treatment for diabetes for almost a century, 
with an extensive evidence base for managing this disorder, there remains 
substantial variation across health systems in the standards of care people 
with diabetes receive. Examining a measure based on the ratio of mortality to 
incidence of diabetes in young people, Nolte, Bain & McKee (2006) found a 
10-fold difference among 29 high- and middle-income countries. 
A number of instruments are now available for use in tracer studies. The 
Rapid Assessment Protocol for Insulin Access (RAPIA) has been developed by 
the International Insulin Foundation as a functional evaluation tool (Yudkin & 
Beran, 2003). It provides a multilevel assessment of the different elements that 
infl uence access to insulin of patients in a given country. Beran, Yudkin and de 
Courten’s 2005 analysis using the RAPIA protocol in Mozambique and Zambia 
showed that, although insulin supplies were suffi cient in these countries, their 
health systems did not permit appropriate distribution according to need, nor 
did they ensure adequate provision of additional equipment or the existence of 
training programmes for health care workers, all factors that increased the risk 
of misdiagnosis or failure to detect diabetes. 
A similar approach was taken in Kyrgyzstan (Hopkinson et al., 2004) and 
Georgia (Balabanova et al., 2009). These studies identifi ed key failings in inte-
gration (ineffective insulin distribution system, lack of necessary equipment, 
complex pathways) that prevented the delivery of quality care for diabetes 
patients despite the existing provision of the essential services (insulin supply, 
training of health professionals, fi nanced care packages). 
While these studies have obvious practical implications for the management 
of diabetes, the use of the tracer approach shows how, even though many 
inputs may be in place, there can still be critical gaps and a failure to integrate 
different aspects of the system. Although such studies focus on a single tracer, 
the problems they identify are often generic. Thus, diabetes can be seen as 
representative of a much larger group of complex chronic diseases that require 
long-term treatment by multidisciplinary teams and the active involvement of 
informed and empowered patients (Nolte et al., 2011). 
5.7 Conclusion 
Many of the existing measures of population health fail to distinguish the 
contribution of health care from extraneous factors and those that do suffer 
from a number of methodological problems. Some of these problems may 
be insurmountable; however, what is important is to understand them and 
take them into account when interpreting data, particularly in the context 
of comparing health systems. Thus, age-standardized mortality from selected 
causes, coupled with additional information on disease prevalence, incidence 
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and survival, can identify areas that justify in-depth investigation. However, 
such investigations must respect the many caveats that can affect cross-national 
comparability. 
The concept of amenable mortality is no more than an indicator of potential 
problems. In international comparisons, it is subject to many methodological 
limitations and depends on achieving consensus on defi nitions and the choice 
of conditions included for analysis. It is a starting point; an accurate diagnosis 
and conclusions will require much more detailed and iterative examination of 
the data that contribute to it. The use of the tracer methodology may be part of 
this further enquiry. 
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